2021 | Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2021 | Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2021 | Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | HEPATOLOGY INTERNATIONAL |
2021 | Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaire | RESEARCH IN NURSING & HEALTH |
2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2021 | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
| CANCERS |
2021 | Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy | HEPATOLOGY INTERNATIONAL |
2021 | The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2021 | Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging | EUROPEAN RADIOLOGY |
2021 | Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
2021 | Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography | EUROPEAN RADIOLOGY |
2021 | Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2021 | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals | JOURNAL OF VIRAL HEPATITIS |
2021 | Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
| GUT AND LIVER |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2021 | From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
| CANCERS |
2021 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Addition of liver stiffness enhances the predictive accuracy of the PAGE-B model for hepatitis B-related hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
2021 | Authors' response: Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | JOURNAL OF VIRAL HEPATITIS |
2021 | Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
| Journal of Liver Cancer(대한간암학회지) |
2021 | A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
| Journal of Liver Cancer(대한간암학회지) |
2021 | Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma | CANCER INVESTIGATION |
2021 | Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
| CURRENT ONCOLOGY |
2021 | Letter to the Editor: Re: Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection | HEPATOLOGY |
2021 | Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
| GUT AND LIVER |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2021 | Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
2021 | Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
2020 | A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy | JOURNAL OF VIRAL HEPATITIS |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2020 | MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy | AMERICAN JOURNAL OF ROENTGENOLOGY |
2020 | Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study | GUT |
2020 | Reply to: "Response to A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma" | JOURNAL OF HEPATOLOGY |
2020 | Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
2020 | Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2020 | The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
| GUT AND LIVER |
2020 | Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
| CANCERS |
2020 | Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B | DIGESTIVE AND LIVER DISEASE |
2020 | Reply to: "Liver stiffness: A novel predictor of postoperative complications in patients with hepatocellular carcinoma" | JOURNAL OF HEPATOLOGY |